| __timestamp | Sanofi | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4667000000 | 581800000 |
| Thursday, January 1, 2015 | 5082000000 | 671900000 |
| Friday, January 1, 2016 | 5232000000 | 876700000 |
| Sunday, January 1, 2017 | 5567000000 | 857900000 |
| Monday, January 1, 2018 | 6350000000 | 822200000 |
| Tuesday, January 1, 2019 | 6018000000 | 778200000 |
| Wednesday, January 1, 2020 | 5529000000 | 512600000 |
| Friday, January 1, 2021 | 5692000000 | 681000000 |
| Saturday, January 1, 2022 | 6706000000 | 662200000 |
| Sunday, January 1, 2023 | 6728000000 | 910700000 |
| Monday, January 1, 2024 | 7394000000 |
Cracking the code
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Sanofi and Viatris Inc. have been at the forefront of this race. From 2014 to 2023, Sanofi consistently outpaced Viatris Inc. in R&D spending, with an average annual expenditure nearly eight times higher. Sanofi's investment peaked in 2023, reaching a staggering 6.7 billion dollars, marking a 44% increase from 2014. In contrast, Viatris Inc. saw a more modest growth, with its R&D spending rising by 57% over the same period, culminating in 910 million dollars in 2023. This disparity highlights Sanofi's aggressive strategy to maintain its competitive edge, while Viatris Inc. focuses on steady, sustainable growth. As the pharmaceutical landscape evolves, these investments will likely shape the future of healthcare innovation.
R&D Insights: How Sanofi and Regeneron Pharmaceuticals, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Sanofi and Insmed Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Sanofi and BioMarin Pharmaceutical Inc.
Comparing Innovation Spending: Sanofi and CymaBay Therapeutics, Inc.
R&D Spending Showdown: Sanofi vs Vericel Corporation
R&D Insights: How Sanofi and Geron Corporation Allocate Funds
Comparing Innovation Spending: Incyte Corporation and Viatris Inc.
Research and Development Investment: Viatris Inc. vs Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Comparing Innovation Spending: Viatris Inc. and HUTCHMED (China) Limited
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
Viatris Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?